These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11590020)

  • 1. A new plasmid display technology for the in vitro selection of functional phenotype-genotype linked proteins.
    Speight RE; Hart DJ; Sutherland JD; Blackburn JM
    Chem Biol; 2001 Oct; 8(10):951-65. PubMed ID: 11590020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a plasmid display system using GAL4 DNA binding domain for the in vitro screening of functional proteins.
    Choi YS; Pack SP; Yoo YJ
    Biotechnol Lett; 2005 Nov; 27(21):1707-11. PubMed ID: 16247679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a plasmid display system with an Oct-1 DNA-binding domain suitable for in vitro screening of engineered proteins.
    Park JH; Kwon HW; Jeong KJ
    J Biosci Bioeng; 2013 Aug; 116(2):246-52. PubMed ID: 23490644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental framework for improved selection of binding proteins using SNAP display.
    Houlihan G; Gatti-Lafranconi P; Kaltenbach M; Lowe D; Hollfelder F
    J Immunol Methods; 2014 Mar; 405():47-56. PubMed ID: 24456628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.
    Morin PJ; Gilmore TD
    Nucleic Acids Res; 1992 May; 20(10):2453-8. PubMed ID: 1598203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the NF-kappaB p50 dimer interface by diversity screening.
    Hart DJ; Speight RE; Sutherland JD; Blackburn JM
    J Mol Biol; 2001 Jul; 310(3):563-75. PubMed ID: 11439024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50.
    King DJ; Bassett SE; Li X; Fennewald SA; Herzog NK; Luxon BA; Shope R; Gorenstein DG
    Biochemistry; 2002 Jul; 41(30):9696-706. PubMed ID: 12135392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation.
    DelaTorre A; Schroeder RA; Kuo PC
    Biochem Biophys Res Commun; 1997 Sep; 238(3):703-6. PubMed ID: 9325152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
    Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
    Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor.
    LeClair KP; Blanar MA; Sharp PA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8145-9. PubMed ID: 1518839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
    Matthews JR; Watson E; Buckley S; Hay RT
    Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.
    Zahnd C; Amstutz P; Plückthun A
    Nat Methods; 2007 Mar; 4(3):269-79. PubMed ID: 17327848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences.
    Urban MB; Baeuerle PA
    New Biol; 1991 Mar; 3(3):279-88. PubMed ID: 1878350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 promoter.
    Gribaudo G; Ravaglia S; Guandalini L; Cavallo R; Gariglio M; Landolfo S
    Virus Res; 1996 Nov; 45(1):15-27. PubMed ID: 8896238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells].
    Gui LL; Zhang CH; Liu ZH; Chen ZJ; Zhu C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):871-5. PubMed ID: 18756949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.
    Kretzschmar M; Meisterernst M; Scheidereit C; Li G; Roeder RG
    Genes Dev; 1992 May; 6(5):761-74. PubMed ID: 1577271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
    J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.